Acute myeloid leukemia trials in China

In China 226 Also abroad 761

226 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Where
Baoding, Bengbu, Chongqing, Guangzhou, Hangzhou, Hefei, Linyi, Nanchang, Shenyang, Suzhou, Tianjin, Zhengzhou
Age
12 years and over
People
160 worldwide
Run by
Sellas Life Sciences Group
See details and how to joinNCT04588922
No phaseTaking people
PD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allo-HSCT
Where
Suzhou
People
43
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT05772273
Phase 2/3Taking people
VA vs DA for Newly Diagnosed Hig-risk AML
Where
Suzhou
Age
18 years to 64 years
People
116
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT05939180
No phaseTaking people
Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study)
Where
Hangzhou
Age
12 years to 60 years
People
138
Run by
First Affiliated Hospital of Zhejiang University
See details and how to joinNCT07183878
Phase 1Taking people
Clinical Trial of CD123-targeted CAR-NK Therapy for Relapse/Refractory AML or BPDCN
Where
Wuhan
Age
18 years to 75 years
People
30
Run by
Chongqing Precision Biotech Co., Ltd
See details and how to joinNCT06690827
Phase 1Enrolling by invitation
A Clinical Study of HY035 Cell Injection in the Treatment of CD7-positive Relapsed or Refractory Hematologic Malignancies
Where
Tianjin
Age
3 years to 70 years
People
13
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07784309
Phase 2Taking people
Venetoclax, Chidamide, and Chiglitazar Sodium (VCC) in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Where
Xiamen
Age
18 years and over
People
30
Run by
The First Affiliated Hospital of Xiamen University
See details and how to joinNCT07783100
Phase 3Taking people
Venetoclax-Azacitidine in Combination With Chidamide and CAG in Fit Older Patients With Acute Myeloid Leukaemia
Where
Beijing
Age
60 years to 75 years
People
120
Run by
Chinese PLA General Hospital
See details and how to joinNCT07514936
No phaseNot yet taking people in China
A Study of VABu Conditioning Regimen in Allo-HSCT for AML Patients
Where
Suzhou
Age
18 years to 70 years
People
42
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT07762508
Phase 1Taking people
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
Where
Beijing, Changchun, Chengdu, Chongqing, Guangzhou, Hangzhou, Hefei, Nanchang, Shengyang, Suzhou, Tianjin, Wuhan, Zhengzhou
Age
18 years and over
People
266 worldwide
Run by
Beijing InnoCare Pharma Tech Co., Ltd.
See details and how to joinNCT06656494
Phase 1/2Taking people
PBSS1113 in Combination With Azacitidine to Treat Patients With AML/MDS
Where
Hangzhou
Age
18 years and over
People
29
Run by
Chaser Therapeutics, Inc.
See details and how to joinNCT07761533
No phaseTaking people
Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients
Where
Hainan
Age
18 years to 75 years
People
30
Run by
Haikou Affiliated Hospital of Central South University Xiangya School of Medicine
See details and how to joinNCT07763054
No phaseTaking people
Intermediate-dose HAD Regimen for CEBPA Double-mutated AML
Where
Tianjin
Age
14 years to 54 years
People
148
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06529250
No phaseTaking people
MRD-positive AML Clinical Study
Where
Tianjin
Age
14 years and over
People
537
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07131059
No phaseTaking people
Multicenter, Platform-type Clinical Study of Refractory/Recurrent Acute Myeloid Leukemia
Where
Tianjin
People
458
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06265545
Phase 3Taking people
Standard-dose vs Intermediate-dose Cytarabine Induction in the Treatment of Acute Myeloid Leukemia With RUNX1-RUNX1T1
Where
Tianjin
Age
14 years to 60 years
People
284
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06744504
No phaseTaking people
Venetoclax, Azacitidine and Liposomal Mitoxantrone for Newly Diagnosed AML
Where
Tianjin
Age
14 years to 100 years
People
27
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07490288
No phaseNot yet taking people in China
Plasma ctDNA Monitoring in Pediatric Acute Leukemia
Where
Tianjin
Age
3 years to 18 years
People
25
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07751588
Phase 2Taking people
Venetoclax Combined With Azacitidine for Consolidation Therapy in AML
Where
Suzhou
Age
18 years and over
People
216
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT07425782
No phaseTaking people
Venetoclax TDM in Newly Diagnosed AML: Exposure-Response and Prognosis
Where
Suzhou
Age
16 years and over
People
50
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT07670130
Phase 2Taking people
VA Consolidation in Intermediate-Risk AML
Where
Suzhou
Age
18 years and over
People
226
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT07672262
Phase 1Taking people
A Phase I Single-arm Clinical Study of Donor NK Cells Infusion Combined With Low-dose Interleukin-2 in the Treatment of Acute Myeloid Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation.
Where
Beijing
Age
18 years and over
People
12
Run by
Peking University First Hospital
See details and how to joinNCT06641648
Phase 2Taking people
A Phase 2 Study of MAX-40279 Combined With Venetoclax and Azacitidine in Unfit Newly Diagnosed Acute Myeloid Leukemia
Where
Tianjin
Age
18 years and over
People
43
Run by
Maxinovel Pty., Ltd.
See details and how to joinNCT07743112
Phase 2Taking people
Study of SA+X in the Treatment of Newly Diagnosed AML
Where
Shanghai
Age
18 years and over
People
205
Run by
Ruijin Hospital
See details and how to joinNCT07548710
Phase 1Taking people
HPB-092 for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia
Where
Tianjin
Age
18 years and over
People
60
Run by
Hangzhou Polymed Biopharmaceuticals, Inc.
See details and how to joinNCT07137637